Chile vs Russian Federation: Treatment success rate for patients treated for MDR-TB
Chile
64.0%
in 2022
Russian Federation
65.0%
in 2022
Chile rank
116th
Russian Federation rank
113th
Treatment success rate for patients treated for MDR-TB over time
- Chile
- Russian Federation
How they compare
Russian Federation currently reports 65.0% against 64.0% in Chile, a difference of 1.0%.
The two have swapped places 6 times across 14 shared years of data; in 2008 it was Russian Federation ahead.
Chile ranks 116th and Russian Federation ranks 113th of 163 countries.
Across the 3 decades both report, Chile averaged higher in 1 and Russian Federation in 2.
Head to head by decade
| Decade | Chile | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.0% | 51.0% | 34.0% | Russian Federation |
| 2010s | 45.2% | 48.4% | 3.2% | Russian Federation |
| 2020s | 59.0% | 56.7% | 2.3% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Chile or Russian Federation?
- Russian Federation, at 65.0% against 64.0% in Chile as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Chile and Russian Federation?
- 1.0%, with Russian Federation ahead.
- How many years of comparable data are there for Chile and Russian Federation?
- 14 years are reported by both, from 2008 to 2022.
- How do Chile and Russian Federation rank globally for treatment success rate for patients treated for mdr-tb?
- Chile ranks 116th and Russian Federation ranks 113th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.